How KM Powers an Enterprise AI Solution at Novartis

First created in 2020 to reduce duplicative efforts in market research related to drug commercialization, the AI-powered knowledge base at Novartis, known as Sherlock, has since expanded to address other use cases, with more potential uses on the horizon. Today, teams across the organization leverage Sherlock to store, search, and repurpose strategic internal and external knowledge, unlocking substantial value for the business.
KM leaders at Novartis, a 2023 recipient of APQC’s Excellence in Knowledge Management (KM) designation, recently discussed with APQC how generative AI fits into their KM strategy. This article synthesizes insights they shared in an August 2024 interview with Lynda Braksiek, APQC’s principal research lead for KM, and a November 2024 webinar.